Division of Gastroenterology and Hepatology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin.
Clin Gastroenterol Hepatol. 2014 Nov;12(11):1783-8. doi: 10.1016/j.cgh.2014.02.013. Epub 2014 Feb 15.
Fecal incontinence is one of the most emotionally devastating of all nonfatal conditions. Many patients do not respond satisfactorily to conservative measures, and there is a need for new and effective strategies when medical therapy fails. The development of sacral nerve stimulation and other forms of neuromodulation and the injection of biologically compatible substances into the anal sphincter complex have brought renewed enthusiasm for using these novel treatments in this underserved population. Because injectable bulking agents such as dextranomer in stabilized hyaluronic acid can be administered in an outpatient setting, this procedure is being marketed to both gastroenterologists and surgeons. This article reviews both sacral nerve stimulation and dextranomer bulking agents and compares their strengths and potential limitations in patients with fecal incontinence.
大便失禁是所有非致命疾病中最具情感破坏性的疾病之一。许多患者对保守治疗反应不佳,当药物治疗失败时,需要新的、有效的治疗策略。骶神经刺激和其他形式的神经调节以及将生物相容物质注入肛门括约肌复合体的发展为在这一服务不足的人群中使用这些新疗法带来了新的热情。由于可在门诊环境中给予诸如稳定透明质酸中的葡聚糖这样的可注射填充剂,因此该程序正在向胃肠病学家和外科医生推销。本文综述了骶神经刺激和葡聚糖填充剂,并比较了它们在大便失禁患者中的优势和潜在局限性。